| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 59.29B | 55.54B | 50.41B | 60.41B | 49.36B | 48.14B | 
| Gross Profit | 32.39B | 29.65B | 25.01B | 31.81B | 26.87B | 26.14B | 
| EBITDA | 12.29B | 10.34B | 7.63B | 16.06B | 14.18B | 15.50B | 
| Net Income | 5.09B | 3.58B | 1.61B | 7.90B | 8.28B | 9.84B | 
| Balance Sheet | ||||||
| Total Assets | 0.00 | 93.36B | 83.87B | 76.60B | 69.68B | 57.51B | 
| Cash, Cash Equivalents and Short-Term Investments | 1.44B | 1.44B | 1.42B | 484.60M | 759.40M | 484.60M | 
| Total Debt | 0.00 | 27.64B | 25.77B | 20.15B | 17.77B | 14.82B | 
| Total Liabilities | -46.03B | 47.33B | 42.71B | 36.12B | 36.09B | 31.50B | 
| Stockholders Equity | 46.03B | 44.73B | 41.11B | 40.38B | 33.51B | 25.98B | 
| Cash Flow | ||||||
| Free Cash Flow | 0.00 | -393.50M | -126.20M | 37.40M | 342.60M | 442.30M | 
| Operating Cash Flow | 0.00 | 6.02B | 6.66B | 9.94B | 9.11B | 7.33B | 
| Investing Cash Flow | 0.00 | -6.82B | -8.22B | -9.96B | -9.14B | -9.41B | 
| Financing Cash Flow | 0.00 | 392.80M | 2.50B | -266.40M | 302.60M | 2.55B | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | ₹318.91B | 41.40 | ― | 0.94% | -2.34% | 6.64% | |
| ― | ₹485.71B | 95.39 | ― | 0.13% | 25.83% | 421.20% | |
| ― | ₹498.48B | 114.16 | ― | 0.13% | 6.80% | -75.66% | |
| ― | ₹326.29B | 41.91 | ― | 0.31% | 11.49% | 35.00% | |
| ― | ₹300.83B | 83.52 | ― | ― | 62.25% | -0.32% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | ₹522.88B | 69.69 | ― | 0.14% | 10.99% | ― | 
Laurus Labs Ltd. announced the availability of the audio recording for their Q2 FY26 results conference call, which was held on October 23, 2025. This update is part of their regulatory compliance and transparency efforts, providing stakeholders with access to detailed financial discussions and company performance insights.